F2RL1 and neoplasm: Connecting these findings, another study reported a significant link of F2RL1, F3, and VEGF-A expression in the clinical setting of primary breast cancer, where patients with phosphorylated F3 and F2RL1-expressed tumor tissue specimen are prone to recurrence.